nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—Skin necrosis—Carmustine—melanoma	0.0216	0.0286	CcSEcCtD
Metolazone—Hypomagnesaemia—Bleomycin—melanoma	0.0136	0.018	CcSEcCtD
Metolazone—Photosensitivity—Vemurafenib—melanoma	0.0118	0.0156	CcSEcCtD
Metolazone—Dry skin—Vemurafenib—melanoma	0.00948	0.0126	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00931	0.0123	CcSEcCtD
Metolazone—Petechiae—Temozolomide—melanoma	0.00885	0.0117	CcSEcCtD
Metolazone—Skin exfoliation—Bleomycin—melanoma	0.00824	0.0109	CcSEcCtD
Metolazone—Photosensitivity reaction—Vemurafenib—melanoma	0.00816	0.0108	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.0079	0.0105	CcSEcCtD
Metolazone—Neuropathy peripheral—Vemurafenib—melanoma	0.00781	0.0104	CcSEcCtD
Metolazone—Skin exfoliation—Carmustine—melanoma	0.00719	0.00954	CcSEcCtD
Metolazone—Neuropathy—Carmustine—melanoma	0.00707	0.00938	CcSEcCtD
Metolazone—Skin exfoliation—Temozolomide—melanoma	0.00695	0.00922	CcSEcCtD
Metolazone—Neuropathy—Temozolomide—melanoma	0.00684	0.00906	CcSEcCtD
Metolazone—Erythema multiforme—Vemurafenib—melanoma	0.00677	0.00897	CcSEcCtD
Metolazone—Throat sore—Docetaxel—melanoma	0.00672	0.00891	CcSEcCtD
Metolazone—Oropharyngeal discomfort—Docetaxel—melanoma	0.00666	0.00883	CcSEcCtD
Metolazone—Chills—Vemurafenib—melanoma	0.00642	0.00851	CcSEcCtD
Metolazone—Swelling—Carmustine—melanoma	0.0062	0.00822	CcSEcCtD
Metolazone—Dysgeusia—Vemurafenib—melanoma	0.0061	0.00809	CcSEcCtD
Metolazone—Back pain—Vemurafenib—melanoma	0.00603	0.00799	CcSEcCtD
Metolazone—Lethargy—Dactinomycin—melanoma	0.00596	0.00791	CcSEcCtD
Metolazone—Vascular purpura—Temozolomide—melanoma	0.00591	0.00783	CcSEcCtD
Metolazone—Hyponatraemia—Carmustine—melanoma	0.00549	0.00728	CcSEcCtD
Metolazone—Purpura—Temozolomide—melanoma	0.00548	0.00727	CcSEcCtD
Metolazone—Cough—Vemurafenib—melanoma	0.00544	0.00721	CcSEcCtD
Metolazone—Oropharyngeal pain—Docetaxel—melanoma	0.00533	0.00706	CcSEcCtD
Metolazone—Arthralgia—Vemurafenib—melanoma	0.0053	0.00703	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00526	0.00698	CcSEcCtD
Metolazone—Hypokalaemia—Carmustine—melanoma	0.00498	0.0066	CcSEcCtD
Metolazone—Dry skin—Temozolomide—melanoma	0.00485	0.00642	CcSEcCtD
Metolazone—Hypokalaemia—Temozolomide—melanoma	0.00481	0.00638	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00476	0.00631	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00463	0.00614	CcSEcCtD
Metolazone—Skin exfoliation—Docetaxel—melanoma	0.00462	0.00613	CcSEcCtD
Metolazone—Abdominal distension—Temozolomide—melanoma	0.0046	0.0061	CcSEcCtD
Metolazone—Neuropathy—Docetaxel—melanoma	0.00455	0.00603	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00447	0.00592	CcSEcCtD
Metolazone—Decreased appetite—Vemurafenib—melanoma	0.00442	0.00586	CcSEcCtD
Metolazone—Fatigue—Vemurafenib—melanoma	0.00438	0.00581	CcSEcCtD
Metolazone—Constipation—Vemurafenib—melanoma	0.00435	0.00576	CcSEcCtD
Metolazone—Lightheadedness—Docetaxel—melanoma	0.00433	0.00574	CcSEcCtD
Metolazone—Hyperglycaemia—Carmustine—melanoma	0.00426	0.00565	CcSEcCtD
Metolazone—Erectile dysfunction—Temozolomide—melanoma	0.00421	0.00558	CcSEcCtD
Metolazone—Agranulocytosis—Dactinomycin—melanoma	0.0042	0.00557	CcSEcCtD
Metolazone—Photosensitivity reaction—Temozolomide—melanoma	0.00417	0.00553	CcSEcCtD
Metolazone—Neuropathy peripheral—Carmustine—melanoma	0.00413	0.00548	CcSEcCtD
Metolazone—Hyperglycaemia—Temozolomide—melanoma	0.00412	0.00546	CcSEcCtD
Metolazone—Hepatitis—Dactinomycin—melanoma	0.00404	0.00536	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00404	0.00535	CcSEcCtD
Metolazone—Neuropathy peripheral—Temozolomide—melanoma	0.00399	0.00529	CcSEcCtD
Metolazone—Swelling—Docetaxel—melanoma	0.00398	0.00528	CcSEcCtD
Metolazone—Chills—Bleomycin—melanoma	0.00389	0.00516	CcSEcCtD
Metolazone—Erythema multiforme—Dactinomycin—melanoma	0.00382	0.00507	CcSEcCtD
Metolazone—Hypersensitivity—Vemurafenib—melanoma	0.00375	0.00497	CcSEcCtD
Metolazone—Hepatitis—Temozolomide—melanoma	0.00366	0.00485	CcSEcCtD
Metolazone—Asthenia—Vemurafenib—melanoma	0.00365	0.00484	CcSEcCtD
Metolazone—Chills—Dactinomycin—melanoma	0.00363	0.00481	CcSEcCtD
Metolazone—Pruritus—Vemurafenib—melanoma	0.0036	0.00477	CcSEcCtD
Metolazone—Lethargy—Docetaxel—melanoma	0.00359	0.00476	CcSEcCtD
Metolazone—Hyponatraemia—Docetaxel—melanoma	0.00353	0.00468	CcSEcCtD
Metolazone—Ill-defined disorder—Bleomycin—melanoma	0.0035	0.00464	CcSEcCtD
Metolazone—Anaemia—Bleomycin—melanoma	0.00349	0.00462	CcSEcCtD
Metolazone—Diarrhoea—Vemurafenib—melanoma	0.00348	0.00461	CcSEcCtD
Metolazone—Erythema multiforme—Temozolomide—melanoma	0.00346	0.00458	CcSEcCtD
Metolazone—Tinnitus—Temozolomide—melanoma	0.00341	0.00452	CcSEcCtD
Metolazone—Malaise—Bleomycin—melanoma	0.0034	0.00451	CcSEcCtD
Metolazone—Leukopenia—Bleomycin—melanoma	0.00338	0.00448	CcSEcCtD
Metolazone—Dizziness—Vemurafenib—melanoma	0.00336	0.00446	CcSEcCtD
Metolazone—Cough—Bleomycin—melanoma	0.00329	0.00437	CcSEcCtD
Metolazone—Chills—Temozolomide—melanoma	0.00328	0.00435	CcSEcCtD
Metolazone—Ill-defined disorder—Dactinomycin—melanoma	0.00327	0.00433	CcSEcCtD
Metolazone—Anaemia—Dactinomycin—melanoma	0.00325	0.00431	CcSEcCtD
Metolazone—Vomiting—Vemurafenib—melanoma	0.00323	0.00429	CcSEcCtD
Metolazone—Dry skin—Docetaxel—melanoma	0.00322	0.00427	CcSEcCtD
Metolazone—Chest pain—Bleomycin—melanoma	0.00321	0.00426	CcSEcCtD
Metolazone—Orthostatic hypotension—Docetaxel—melanoma	0.00321	0.00426	CcSEcCtD
Metolazone—Rash—Vemurafenib—melanoma	0.00321	0.00425	CcSEcCtD
Metolazone—Dermatitis—Vemurafenib—melanoma	0.0032	0.00425	CcSEcCtD
Metolazone—Back pain—Carmustine—melanoma	0.00319	0.00422	CcSEcCtD
Metolazone—Headache—Vemurafenib—melanoma	0.00318	0.00422	CcSEcCtD
Metolazone—Discomfort—Bleomycin—melanoma	0.00317	0.00421	CcSEcCtD
Metolazone—Malaise—Dactinomycin—melanoma	0.00317	0.00421	CcSEcCtD
Metolazone—Cramp muscle—Docetaxel—melanoma	0.00317	0.0042	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00317	0.0042	CcSEcCtD
Metolazone—Leukopenia—Dactinomycin—melanoma	0.00315	0.00418	CcSEcCtD
Metolazone—Dysgeusia—Temozolomide—melanoma	0.00312	0.00413	CcSEcCtD
Metolazone—Vision blurred—Carmustine—melanoma	0.0031	0.00412	CcSEcCtD
Metolazone—Back pain—Temozolomide—melanoma	0.00308	0.00408	CcSEcCtD
Metolazone—Anaemia—Carmustine—melanoma	0.00304	0.00404	CcSEcCtD
Metolazone—Agitation—Carmustine—melanoma	0.00303	0.00401	CcSEcCtD
Metolazone—Nausea—Vemurafenib—melanoma	0.00302	0.004	CcSEcCtD
Metolazone—Thrombocytopenia—Bleomycin—melanoma	0.00302	0.004	CcSEcCtD
Metolazone—Vision blurred—Temozolomide—melanoma	0.003	0.00398	CcSEcCtD
Metolazone—Discomfort—Dactinomycin—melanoma	0.00296	0.00393	CcSEcCtD
Metolazone—Ill-defined disorder—Temozolomide—melanoma	0.00295	0.00392	CcSEcCtD
Metolazone—Leukopenia—Carmustine—melanoma	0.00295	0.00391	CcSEcCtD
Metolazone—Anaemia—Temozolomide—melanoma	0.00294	0.0039	CcSEcCtD
Metolazone—Anorexia—Bleomycin—melanoma	0.00294	0.00389	CcSEcCtD
Metolazone—Agitation—Temozolomide—melanoma	0.00293	0.00388	CcSEcCtD
Metolazone—Malaise—Temozolomide—melanoma	0.00287	0.00381	CcSEcCtD
Metolazone—Vertigo—Temozolomide—melanoma	0.00286	0.00379	CcSEcCtD
Metolazone—Leukopenia—Temozolomide—melanoma	0.00285	0.00378	CcSEcCtD
Metolazone—Hypertension—Carmustine—melanoma	0.00284	0.00377	CcSEcCtD
Metolazone—Palpitations—Temozolomide—melanoma	0.00281	0.00373	CcSEcCtD
Metolazone—Thrombocytopenia—Dactinomycin—melanoma	0.00281	0.00373	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Bleomycin—melanoma	0.00281	0.00372	CcSEcCtD
Metolazone—Chest pain—Carmustine—melanoma	0.0028	0.00372	CcSEcCtD
Metolazone—Anxiety—Carmustine—melanoma	0.00279	0.00371	CcSEcCtD
Metolazone—Cough—Temozolomide—melanoma	0.00278	0.00368	CcSEcCtD
Metolazone—Paraesthesia—Bleomycin—melanoma	0.00277	0.00367	CcSEcCtD
Metolazone—Hypertension—Temozolomide—melanoma	0.00275	0.00364	CcSEcCtD
Metolazone—Anorexia—Dactinomycin—melanoma	0.00274	0.00363	CcSEcCtD
Metolazone—Arthralgia—Temozolomide—melanoma	0.00271	0.00359	CcSEcCtD
Metolazone—Anxiety—Temozolomide—melanoma	0.0027	0.00358	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00269	0.00356	CcSEcCtD
Metolazone—Discomfort—Temozolomide—melanoma	0.00268	0.00355	CcSEcCtD
Metolazone—Decreased appetite—Bleomycin—melanoma	0.00268	0.00355	CcSEcCtD
Metolazone—Neuropathy peripheral—Docetaxel—melanoma	0.00266	0.00352	CcSEcCtD
Metolazone—Dry mouth—Temozolomide—melanoma	0.00265	0.00351	CcSEcCtD
Metolazone—Pain—Bleomycin—melanoma	0.00263	0.00349	CcSEcCtD
Metolazone—Thrombocytopenia—Carmustine—melanoma	0.00263	0.00349	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00262	0.00347	CcSEcCtD
Metolazone—Anorexia—Carmustine—melanoma	0.00256	0.0034	CcSEcCtD
Metolazone—Epistaxis—Docetaxel—melanoma	0.00256	0.00339	CcSEcCtD
Metolazone—Thrombocytopenia—Temozolomide—melanoma	0.00254	0.00337	CcSEcCtD
Metolazone—Feeling abnormal—Bleomycin—melanoma	0.00254	0.00337	CcSEcCtD
Metolazone—Agranulocytosis—Docetaxel—melanoma	0.00253	0.00335	CcSEcCtD
Metolazone—Decreased appetite—Dactinomycin—melanoma	0.0025	0.00331	CcSEcCtD
Metolazone—Fatigue—Dactinomycin—melanoma	0.00248	0.00328	CcSEcCtD
Metolazone—Anorexia—Temozolomide—melanoma	0.00248	0.00328	CcSEcCtD
Metolazone—Pain—Dactinomycin—melanoma	0.00246	0.00326	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Carmustine—melanoma	0.00245	0.00325	CcSEcCtD
Metolazone—Urticaria—Bleomycin—melanoma	0.00245	0.00324	CcSEcCtD
Metolazone—Hepatitis—Docetaxel—melanoma	0.00243	0.00322	CcSEcCtD
Metolazone—Insomnia—Carmustine—melanoma	0.00243	0.00322	CcSEcCtD
Metolazone—Paraesthesia—Carmustine—melanoma	0.00241	0.0032	CcSEcCtD
Metolazone—Somnolence—Carmustine—melanoma	0.00239	0.00317	CcSEcCtD
Metolazone—Feeling abnormal—Dactinomycin—melanoma	0.00237	0.00314	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Temozolomide—melanoma	0.00237	0.00314	CcSEcCtD
Metolazone—Insomnia—Temozolomide—melanoma	0.00235	0.00312	CcSEcCtD
Metolazone—Gastrointestinal pain—Dactinomycin—melanoma	0.00235	0.00311	CcSEcCtD
Metolazone—Decreased appetite—Carmustine—melanoma	0.00234	0.0031	CcSEcCtD
Metolazone—Paraesthesia—Temozolomide—melanoma	0.00233	0.00309	CcSEcCtD
Metolazone—Somnolence—Temozolomide—melanoma	0.00231	0.00306	CcSEcCtD
Metolazone—Erythema multiforme—Docetaxel—melanoma	0.0023	0.00305	CcSEcCtD
Metolazone—Pain—Carmustine—melanoma	0.0023	0.00305	CcSEcCtD
Metolazone—Constipation—Carmustine—melanoma	0.0023	0.00305	CcSEcCtD
Metolazone—Dyspepsia—Temozolomide—melanoma	0.00229	0.00303	CcSEcCtD
Metolazone—Abdominal pain—Dactinomycin—melanoma	0.00227	0.00301	CcSEcCtD
Metolazone—Hypersensitivity—Bleomycin—melanoma	0.00227	0.00301	CcSEcCtD
Metolazone—Decreased appetite—Temozolomide—melanoma	0.00226	0.00299	CcSEcCtD
Metolazone—Fatigue—Temozolomide—melanoma	0.00224	0.00297	CcSEcCtD
Metolazone—Constipation—Temozolomide—melanoma	0.00222	0.00295	CcSEcCtD
Metolazone—Pain—Temozolomide—melanoma	0.00222	0.00295	CcSEcCtD
Metolazone—Feeling abnormal—Carmustine—melanoma	0.00222	0.00294	CcSEcCtD
Metolazone—Asthenia—Bleomycin—melanoma	0.00221	0.00293	CcSEcCtD
Metolazone—Gastrointestinal pain—Carmustine—melanoma	0.0022	0.00291	CcSEcCtD
Metolazone—Chills—Docetaxel—melanoma	0.00218	0.00289	CcSEcCtD
Metolazone—Pruritus—Bleomycin—melanoma	0.00218	0.00289	CcSEcCtD
Metolazone—Feeling abnormal—Temozolomide—melanoma	0.00214	0.00284	CcSEcCtD
Metolazone—Abdominal pain—Carmustine—melanoma	0.00213	0.00282	CcSEcCtD
Metolazone—Gastrointestinal pain—Temozolomide—melanoma	0.00212	0.00282	CcSEcCtD
Metolazone—Hypersensitivity—Dactinomycin—melanoma	0.00212	0.00281	CcSEcCtD
Metolazone—Dysgeusia—Docetaxel—melanoma	0.00207	0.00275	CcSEcCtD
Metolazone—Urticaria—Temozolomide—melanoma	0.00206	0.00274	CcSEcCtD
Metolazone—Asthenia—Dactinomycin—melanoma	0.00206	0.00273	CcSEcCtD
Metolazone—Abdominal pain—Temozolomide—melanoma	0.00205	0.00272	CcSEcCtD
Metolazone—Back pain—Docetaxel—melanoma	0.00205	0.00272	CcSEcCtD
Metolazone—Muscle spasms—Docetaxel—melanoma	0.00204	0.0027	CcSEcCtD
Metolazone—Hypersensitivity—Carmustine—melanoma	0.00198	0.00263	CcSEcCtD
Metolazone—Diarrhoea—Dactinomycin—melanoma	0.00197	0.00261	CcSEcCtD
Metolazone—Vomiting—Bleomycin—melanoma	0.00196	0.0026	CcSEcCtD
Metolazone—Anaemia—Docetaxel—melanoma	0.00196	0.00259	CcSEcCtD
Metolazone—Rash—Bleomycin—melanoma	0.00194	0.00257	CcSEcCtD
Metolazone—Dermatitis—Bleomycin—melanoma	0.00194	0.00257	CcSEcCtD
Metolazone—Asthenia—Carmustine—melanoma	0.00193	0.00256	CcSEcCtD
Metolazone—Hypersensitivity—Temozolomide—melanoma	0.00191	0.00254	CcSEcCtD
Metolazone—Syncope—Docetaxel—melanoma	0.0019	0.00252	CcSEcCtD
Metolazone—Leukopenia—Docetaxel—melanoma	0.00189	0.00251	CcSEcCtD
Metolazone—Palpitations—Docetaxel—melanoma	0.00187	0.00248	CcSEcCtD
Metolazone—Asthenia—Temozolomide—melanoma	0.00186	0.00247	CcSEcCtD
Metolazone—Loss of consciousness—Docetaxel—melanoma	0.00186	0.00247	CcSEcCtD
Metolazone—Cough—Docetaxel—melanoma	0.00185	0.00245	CcSEcCtD
Metolazone—Diarrhoea—Carmustine—melanoma	0.00184	0.00244	CcSEcCtD
Metolazone—Pruritus—Temozolomide—melanoma	0.00184	0.00244	CcSEcCtD
Metolazone—Nausea—Bleomycin—melanoma	0.00183	0.00243	CcSEcCtD
Metolazone—Hypertension—Docetaxel—melanoma	0.00183	0.00242	CcSEcCtD
Metolazone—Vomiting—Dactinomycin—melanoma	0.00183	0.00242	CcSEcCtD
Metolazone—Rash—Dactinomycin—melanoma	0.00181	0.0024	CcSEcCtD
Metolazone—Arthralgia—Docetaxel—melanoma	0.0018	0.00239	CcSEcCtD
Metolazone—Chest pain—Docetaxel—melanoma	0.0018	0.00239	CcSEcCtD
Metolazone—Dizziness—Carmustine—melanoma	0.00178	0.00236	CcSEcCtD
Metolazone—Diarrhoea—Temozolomide—melanoma	0.00178	0.00236	CcSEcCtD
Metolazone—Dry mouth—Docetaxel—melanoma	0.00176	0.00234	CcSEcCtD
Metolazone—Dizziness—Temozolomide—melanoma	0.00172	0.00228	CcSEcCtD
Metolazone—Vomiting—Carmustine—melanoma	0.00171	0.00227	CcSEcCtD
Metolazone—Nausea—Dactinomycin—melanoma	0.00171	0.00226	CcSEcCtD
Metolazone—Shock—Docetaxel—melanoma	0.0017	0.00225	CcSEcCtD
Metolazone—Rash—Carmustine—melanoma	0.0017	0.00225	CcSEcCtD
Metolazone—Dermatitis—Carmustine—melanoma	0.00169	0.00225	CcSEcCtD
Metolazone—Thrombocytopenia—Docetaxel—melanoma	0.00169	0.00224	CcSEcCtD
Metolazone—Headache—Carmustine—melanoma	0.00168	0.00223	CcSEcCtD
Metolazone—Vomiting—Temozolomide—melanoma	0.00165	0.00219	CcSEcCtD
Metolazone—Anorexia—Docetaxel—melanoma	0.00165	0.00218	CcSEcCtD
Metolazone—Rash—Temozolomide—melanoma	0.00164	0.00217	CcSEcCtD
Metolazone—Dermatitis—Temozolomide—melanoma	0.00164	0.00217	CcSEcCtD
Metolazone—Headache—Temozolomide—melanoma	0.00163	0.00216	CcSEcCtD
Metolazone—Nausea—Carmustine—melanoma	0.0016	0.00212	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Docetaxel—melanoma	0.00157	0.00209	CcSEcCtD
Metolazone—Insomnia—Docetaxel—melanoma	0.00156	0.00207	CcSEcCtD
Metolazone—Paraesthesia—Docetaxel—melanoma	0.00155	0.00206	CcSEcCtD
Metolazone—Nausea—Temozolomide—melanoma	0.00154	0.00205	CcSEcCtD
Metolazone—Somnolence—Docetaxel—melanoma	0.00154	0.00204	CcSEcCtD
Metolazone—Dyspepsia—Docetaxel—melanoma	0.00152	0.00202	CcSEcCtD
Metolazone—Decreased appetite—Docetaxel—melanoma	0.0015	0.00199	CcSEcCtD
Metolazone—Fatigue—Docetaxel—melanoma	0.00149	0.00197	CcSEcCtD
Metolazone—Pain—Docetaxel—melanoma	0.00148	0.00196	CcSEcCtD
Metolazone—Constipation—Docetaxel—melanoma	0.00148	0.00196	CcSEcCtD
Metolazone—Feeling abnormal—Docetaxel—melanoma	0.00142	0.00189	CcSEcCtD
Metolazone—Gastrointestinal pain—Docetaxel—melanoma	0.00141	0.00187	CcSEcCtD
Metolazone—Abdominal pain—Docetaxel—melanoma	0.00137	0.00181	CcSEcCtD
Metolazone—CA9—HIF-1-alpha transcription factor network—NOS2—melanoma	0.00136	0.00554	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00128	0.00519	CbGpPWpGaD
Metolazone—Hypersensitivity—Docetaxel—melanoma	0.00127	0.00169	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—ID1—melanoma	0.00124	0.00506	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MAP3K5—melanoma	0.00124	0.00506	CbGpPWpGaD
Metolazone—Asthenia—Docetaxel—melanoma	0.00124	0.00164	CcSEcCtD
Metolazone—CA5A—Metabolism—ACER3—melanoma	0.00123	0.00502	CbGpPWpGaD
Metolazone—Pruritus—Docetaxel—melanoma	0.00122	0.00162	CcSEcCtD
Metolazone—Diarrhoea—Docetaxel—melanoma	0.00118	0.00157	CcSEcCtD
Metolazone—CA7—Metabolism—ACER3—melanoma	0.00115	0.00469	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ACER3—melanoma	0.00115	0.00469	CbGpPWpGaD
Metolazone—SLC12A3—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.00115	0.00467	CbGpPWpGaD
Metolazone—Dizziness—Docetaxel—melanoma	0.00114	0.00151	CcSEcCtD
Metolazone—CA5A—Metabolism—UGT2B10—melanoma	0.00113	0.00459	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—HDAC6—melanoma	0.00111	0.00453	CbGpPWpGaD
Metolazone—Vomiting—Docetaxel—melanoma	0.0011	0.00146	CcSEcCtD
Metolazone—Rash—Docetaxel—melanoma	0.00109	0.00144	CcSEcCtD
Metolazone—Dermatitis—Docetaxel—melanoma	0.00109	0.00144	CcSEcCtD
Metolazone—Headache—Docetaxel—melanoma	0.00108	0.00144	CcSEcCtD
Metolazone—CA12—Metabolism—ACER3—melanoma	0.00107	0.00434	CbGpPWpGaD
Metolazone—CA5B—Metabolism—UGT2B10—melanoma	0.00105	0.00429	CbGpPWpGaD
Metolazone—CA7—Metabolism—UGT2B10—melanoma	0.00105	0.00429	CbGpPWpGaD
Metolazone—CA5A—Metabolism—HS3ST5—melanoma	0.00105	0.00427	CbGpPWpGaD
Metolazone—Nausea—Docetaxel—melanoma	0.00103	0.00136	CcSEcCtD
Metolazone—CA7—Metabolism—HS3ST5—melanoma	0.00098	0.00399	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HS3ST5—melanoma	0.00098	0.00399	CbGpPWpGaD
Metolazone—CA12—Metabolism—UGT2B10—melanoma	0.000976	0.00397	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—ETS1—melanoma	0.000942	0.00383	CbGpPWpGaD
Metolazone—CA12—Metabolism—HS3ST5—melanoma	0.000908	0.00369	CbGpPWpGaD
Metolazone—CA4—Metabolism—ACER3—melanoma	0.000851	0.00346	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—EPO—melanoma	0.000829	0.00337	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PLCB4—melanoma	0.000795	0.00324	CbGpPWpGaD
Metolazone—CA9—HIF-1-alpha transcription factor network—VEGFA—melanoma	0.000788	0.00321	CbGpPWpGaD
Metolazone—CA4—Metabolism—UGT2B10—melanoma	0.000778	0.00317	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—IFNB1—melanoma	0.000758	0.00309	CbGpPWpGaD
Metolazone—CA5A—Metabolism—SLC6A11—melanoma	0.000748	0.00304	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIP4K2A—melanoma	0.000748	0.00304	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PLCB4—melanoma	0.000742	0.00302	CbGpPWpGaD
Metolazone—CA7—Metabolism—PLCB4—melanoma	0.000742	0.00302	CbGpPWpGaD
Metolazone—CA5A—Metabolism—MTAP—melanoma	0.000727	0.00296	CbGpPWpGaD
Metolazone—CA4—Metabolism—HS3ST5—melanoma	0.000724	0.00294	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SLC6A11—melanoma	0.000698	0.00284	CbGpPWpGaD
Metolazone—CA7—Metabolism—SLC6A11—melanoma	0.000698	0.00284	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIP4K2A—melanoma	0.000698	0.00284	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIP4K2A—melanoma	0.000698	0.00284	CbGpPWpGaD
Metolazone—CA12—Metabolism—PLCB4—melanoma	0.000688	0.0028	CbGpPWpGaD
Metolazone—CA9—Metabolism—ACER3—melanoma	0.000688	0.0028	CbGpPWpGaD
Metolazone—CA7—Metabolism—MTAP—melanoma	0.000679	0.00276	CbGpPWpGaD
Metolazone—CA5B—Metabolism—MTAP—melanoma	0.000679	0.00276	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PHGDH—melanoma	0.000648	0.00264	CbGpPWpGaD
Metolazone—CA5A—Metabolism—LUM—melanoma	0.000648	0.00264	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIP4K2A—melanoma	0.000647	0.00263	CbGpPWpGaD
Metolazone—CA12—Metabolism—SLC6A11—melanoma	0.000647	0.00263	CbGpPWpGaD
Metolazone—CA5A—Metabolism—HPSE—melanoma	0.000636	0.00259	CbGpPWpGaD
Metolazone—CA9—Metabolism—UGT2B10—melanoma	0.000629	0.00256	CbGpPWpGaD
Metolazone—CA12—Metabolism—MTAP—melanoma	0.000629	0.00256	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CUBN—melanoma	0.000624	0.00254	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CDKN2B—melanoma	0.000617	0.00251	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PHGDH—melanoma	0.000605	0.00246	CbGpPWpGaD
Metolazone—CA7—Metabolism—PHGDH—melanoma	0.000605	0.00246	CbGpPWpGaD
Metolazone—CA7—Metabolism—LUM—melanoma	0.000605	0.00246	CbGpPWpGaD
Metolazone—CA5B—Metabolism—LUM—melanoma	0.000605	0.00246	CbGpPWpGaD
Metolazone—CA5A—Metabolism—SDHD—melanoma	0.000603	0.00245	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CSPG4—melanoma	0.000603	0.00245	CbGpPWpGaD
Metolazone—CA5A—Metabolism—BSG—melanoma	0.000603	0.00245	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HPSE—melanoma	0.000594	0.00241	CbGpPWpGaD
Metolazone—CA7—Metabolism—HPSE—melanoma	0.000594	0.00241	CbGpPWpGaD
Metolazone—CA9—Metabolism—HS3ST5—melanoma	0.000585	0.00238	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GPAM—melanoma	0.000584	0.00237	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000584	0.00237	CbGpPWpGaD
Metolazone—CA7—Metabolism—CUBN—melanoma	0.000583	0.00237	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CUBN—melanoma	0.000583	0.00237	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—E2F1—melanoma	0.000567	0.00231	CbGpPWpGaD
Metolazone—CA7—Metabolism—CSPG4—melanoma	0.000563	0.00229	CbGpPWpGaD
Metolazone—CA5B—Metabolism—BSG—melanoma	0.000563	0.00229	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SDHD—melanoma	0.000563	0.00229	CbGpPWpGaD
Metolazone—CA7—Metabolism—BSG—melanoma	0.000563	0.00229	CbGpPWpGaD
Metolazone—CA7—Metabolism—SDHD—melanoma	0.000563	0.00229	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CSPG4—melanoma	0.000563	0.00229	CbGpPWpGaD
Metolazone—CA12—Metabolism—PHGDH—melanoma	0.000561	0.00228	CbGpPWpGaD
Metolazone—CA12—Metabolism—LUM—melanoma	0.000561	0.00228	CbGpPWpGaD
Metolazone—CA12—Metabolism—HPSE—melanoma	0.00055	0.00224	CbGpPWpGaD
Metolazone—CA4—Metabolism—PLCB4—melanoma	0.000548	0.00223	CbGpPWpGaD
Metolazone—SLC12A3—SLC-mediated transmembrane transport—ALB—melanoma	0.000548	0.00223	CbGpPWpGaD
Metolazone—CA7—Metabolism—GPAM—melanoma	0.000545	0.00222	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GPAM—melanoma	0.000545	0.00222	CbGpPWpGaD
Metolazone—CA12—Metabolism—CUBN—melanoma	0.00054	0.0022	CbGpPWpGaD
Metolazone—CA12—Metabolism—SDHD—melanoma	0.000521	0.00212	CbGpPWpGaD
Metolazone—CA12—Metabolism—BSG—melanoma	0.000521	0.00212	CbGpPWpGaD
Metolazone—CA12—Metabolism—CSPG4—melanoma	0.000521	0.00212	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC6A11—melanoma	0.000516	0.0021	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIP4K2A—melanoma	0.000516	0.0021	CbGpPWpGaD
Metolazone—CA12—Metabolism—GPAM—melanoma	0.000505	0.00205	CbGpPWpGaD
Metolazone—CA9—HIF-1-alpha transcription factor network—AKT1—melanoma	0.000503	0.00205	CbGpPWpGaD
Metolazone—CA4—Metabolism—MTAP—melanoma	0.000502	0.00204	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PLA2G6—melanoma	0.000496	0.00202	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—HIF1A—melanoma	0.000493	0.00201	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CDK2—melanoma	0.000489	0.00199	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—ATM—melanoma	0.000464	0.00189	CbGpPWpGaD
Metolazone—CA7—Metabolism—PLA2G6—melanoma	0.000463	0.00189	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PLA2G6—melanoma	0.000463	0.00189	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CDK4—melanoma	0.000462	0.00188	CbGpPWpGaD
Metolazone—CA4—Metabolism—LUM—melanoma	0.000447	0.00182	CbGpPWpGaD
Metolazone—CA4—Metabolism—PHGDH—melanoma	0.000447	0.00182	CbGpPWpGaD
Metolazone—CA5A—Metabolism—VCAN—melanoma	0.000446	0.00181	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ABCB1—melanoma	0.000445	0.00181	CbGpPWpGaD
Metolazone—CA9—Metabolism—PLCB4—melanoma	0.000443	0.0018	CbGpPWpGaD
Metolazone—CA4—Metabolism—HPSE—melanoma	0.000438	0.00178	CbGpPWpGaD
Metolazone—CA4—Metabolism—CUBN—melanoma	0.00043	0.00175	CbGpPWpGaD
Metolazone—CA12—Metabolism—PLA2G6—melanoma	0.000429	0.00175	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIP4K2A—melanoma	0.000417	0.0017	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC6A11—melanoma	0.000417	0.0017	CbGpPWpGaD
Metolazone—CA5B—Metabolism—VCAN—melanoma	0.000416	0.00169	CbGpPWpGaD
Metolazone—CA7—Metabolism—VCAN—melanoma	0.000416	0.00169	CbGpPWpGaD
Metolazone—CA4—Metabolism—SDHD—melanoma	0.000416	0.00169	CbGpPWpGaD
Metolazone—CA4—Metabolism—BSG—melanoma	0.000416	0.00169	CbGpPWpGaD
Metolazone—CA4—Metabolism—CSPG4—melanoma	0.000416	0.00169	CbGpPWpGaD
Metolazone—CA9—Metabolism—MTAP—melanoma	0.000405	0.00165	CbGpPWpGaD
Metolazone—CA4—Metabolism—GPAM—melanoma	0.000403	0.00164	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—RB1—melanoma	0.000402	0.00163	CbGpPWpGaD
Metolazone—CA12—Metabolism—VCAN—melanoma	0.000386	0.00157	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP17A1—melanoma	0.000376	0.00153	CbGpPWpGaD
Metolazone—CA9—Metabolism—PHGDH—melanoma	0.000361	0.00147	CbGpPWpGaD
Metolazone—CA9—Metabolism—LUM—melanoma	0.000361	0.00147	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GNA11—melanoma	0.000355	0.00145	CbGpPWpGaD
Metolazone—CA9—Metabolism—HPSE—melanoma	0.000354	0.00144	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CDKN2A—melanoma	0.000353	0.00144	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP17A1—melanoma	0.000351	0.00143	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP17A1—melanoma	0.000351	0.00143	CbGpPWpGaD
Metolazone—CA9—Metabolism—CUBN—melanoma	0.000348	0.00142	CbGpPWpGaD
Metolazone—CA5A—Metabolism—FASN—melanoma	0.000348	0.00141	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MDM2—melanoma	0.000342	0.00139	CbGpPWpGaD
Metolazone—CA4—Metabolism—PLA2G6—melanoma	0.000342	0.00139	CbGpPWpGaD
Metolazone—CA5A—Metabolism—SLC5A5—melanoma	0.000342	0.00139	CbGpPWpGaD
Metolazone—CA9—Metabolism—SDHD—melanoma	0.000336	0.00137	CbGpPWpGaD
Metolazone—CA9—Metabolism—CSPG4—melanoma	0.000336	0.00137	CbGpPWpGaD
Metolazone—CA9—Metabolism—BSG—melanoma	0.000336	0.00137	CbGpPWpGaD
Metolazone—CA7—Metabolism—GNA11—melanoma	0.000332	0.00135	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GNA11—melanoma	0.000332	0.00135	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GNAQ—melanoma	0.00033	0.00134	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CD44—melanoma	0.00033	0.00134	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP17A1—melanoma	0.000325	0.00132	CbGpPWpGaD
Metolazone—CA9—Metabolism—GPAM—melanoma	0.000325	0.00132	CbGpPWpGaD
Metolazone—CA7—Metabolism—FASN—melanoma	0.000325	0.00132	CbGpPWpGaD
Metolazone—CA5B—Metabolism—FASN—melanoma	0.000325	0.00132	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CXCL8—melanoma	0.00032	0.0013	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SLC5A5—melanoma	0.000319	0.0013	CbGpPWpGaD
Metolazone—CA7—Metabolism—SLC5A5—melanoma	0.000319	0.0013	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP1B1—melanoma	0.000317	0.00129	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CDKN1B—melanoma	0.000313	0.00127	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GNAQ—melanoma	0.000308	0.00125	CbGpPWpGaD
Metolazone—CA7—Metabolism—GNAQ—melanoma	0.000308	0.00125	CbGpPWpGaD
Metolazone—CA7—Metabolism—CD44—melanoma	0.000308	0.00125	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CD44—melanoma	0.000308	0.00125	CbGpPWpGaD
Metolazone—CA4—Metabolism—VCAN—melanoma	0.000307	0.00125	CbGpPWpGaD
Metolazone—CA12—Metabolism—GNA11—melanoma	0.000307	0.00125	CbGpPWpGaD
Metolazone—CA12—Metabolism—FASN—melanoma	0.000301	0.00122	CbGpPWpGaD
Metolazone—CA12—Metabolism—SLC5A5—melanoma	0.000296	0.0012	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP1B1—melanoma	0.000296	0.0012	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP1B1—melanoma	0.000296	0.0012	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CDKN1A—melanoma	0.000289	0.00117	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—NFKB1—melanoma	0.000286	0.00117	CbGpPWpGaD
Metolazone—CA12—Metabolism—GNAQ—melanoma	0.000286	0.00116	CbGpPWpGaD
Metolazone—CA12—Metabolism—CD44—melanoma	0.000286	0.00116	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ALB—melanoma	0.000278	0.00113	CbGpPWpGaD
Metolazone—CA9—Metabolism—PLA2G6—melanoma	0.000277	0.00113	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP1B1—melanoma	0.000274	0.00111	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ABCB1—melanoma	0.000261	0.00106	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—VEGFA—melanoma	0.00026	0.00106	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP17A1—melanoma	0.000259	0.00106	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—STAT3—melanoma	0.000257	0.00105	CbGpPWpGaD
Metolazone—CA9—Metabolism—VCAN—melanoma	0.000248	0.00101	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MAPK3—melanoma	0.000246	0.001	CbGpPWpGaD
Metolazone—CA4—Metabolism—GNA11—melanoma	0.000245	0.000997	CbGpPWpGaD
Metolazone—CA7—Metabolism—ABCB1—melanoma	0.000243	0.00099	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ABCB1—melanoma	0.000243	0.00099	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PRKCA—melanoma	0.00024	0.000976	CbGpPWpGaD
Metolazone—CA4—Metabolism—FASN—melanoma	0.00024	0.000976	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ERCC2—melanoma	0.000238	0.000968	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC5A5—melanoma	0.000236	0.00096	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MAPK1—melanoma	0.000234	0.000952	CbGpPWpGaD
Metolazone—CA4—Metabolism—GNAQ—melanoma	0.000228	0.000927	CbGpPWpGaD
Metolazone—CA4—Metabolism—CD44—melanoma	0.000228	0.000927	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCB1—melanoma	0.000225	0.000917	CbGpPWpGaD
Metolazone—CA7—Metabolism—PRKCA—melanoma	0.000224	0.000911	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PRKCA—melanoma	0.000224	0.000911	CbGpPWpGaD
Metolazone—CA7—Metabolism—ERCC2—melanoma	0.000222	0.000904	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ERCC2—melanoma	0.000222	0.000904	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP1B1—melanoma	0.000218	0.000888	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP17A1—melanoma	0.00021	0.000853	CbGpPWpGaD
Metolazone—CA12—Metabolism—PRKCA—melanoma	0.000208	0.000844	CbGpPWpGaD
Metolazone—CA12—Metabolism—ERCC2—melanoma	0.000206	0.000837	CbGpPWpGaD
Metolazone—CA9—Metabolism—GNA11—melanoma	0.000198	0.000805	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—TP53—melanoma	0.000196	0.000799	CbGpPWpGaD
Metolazone—CA9—Metabolism—FASN—melanoma	0.000194	0.000788	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC5A5—melanoma	0.000191	0.000775	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CG—melanoma	0.000188	0.000765	CbGpPWpGaD
Metolazone—CA9—Metabolism—GNAQ—melanoma	0.000184	0.000749	CbGpPWpGaD
Metolazone—CA9—Metabolism—CD44—melanoma	0.000184	0.000749	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPARG—melanoma	0.000181	0.000738	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—IL6—melanoma	0.00018	0.000732	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCB1—melanoma	0.00018	0.000732	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP1B1—melanoma	0.000176	0.000718	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CG—melanoma	0.000175	0.000714	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CG—melanoma	0.000175	0.000714	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPARG—melanoma	0.000169	0.000689	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPARG—melanoma	0.000169	0.000689	CbGpPWpGaD
Metolazone—CA4—Metabolism—PRKCA—melanoma	0.000165	0.000673	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CD—melanoma	0.000165	0.000672	CbGpPWpGaD
Metolazone—CA4—Metabolism—ERCC2—melanoma	0.000164	0.000668	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ALB—melanoma	0.000163	0.000664	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CG—melanoma	0.000163	0.000661	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPARG—melanoma	0.000157	0.000638	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CD—melanoma	0.000154	0.000628	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CD—melanoma	0.000154	0.000628	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALB—melanoma	0.000152	0.00062	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALB—melanoma	0.000152	0.00062	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCB1—melanoma	0.000145	0.000591	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CB—melanoma	0.000144	0.000586	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CD—melanoma	0.000143	0.000581	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTGS2—melanoma	0.000143	0.000581	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALB—melanoma	0.000141	0.000574	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CB—melanoma	0.000134	0.000547	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CB—melanoma	0.000134	0.000547	CbGpPWpGaD
Metolazone—CA9—Metabolism—PRKCA—melanoma	0.000134	0.000544	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTGS2—melanoma	0.000133	0.000542	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTGS2—melanoma	0.000133	0.000542	CbGpPWpGaD
Metolazone—CA9—Metabolism—ERCC2—melanoma	0.000133	0.00054	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CG—melanoma	0.00013	0.000527	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPARG—melanoma	0.000125	0.000509	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CB—melanoma	0.000125	0.000507	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTEN—melanoma	0.000124	0.000506	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTGS2—melanoma	0.000123	0.000502	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTEN—melanoma	0.000116	0.000473	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTEN—melanoma	0.000116	0.000473	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CD—melanoma	0.000114	0.000464	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALB—melanoma	0.000112	0.000458	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTEN—melanoma	0.000108	0.000438	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CG—melanoma	0.000105	0.000426	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPARG—melanoma	0.000101	0.000411	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CB—melanoma	9.93e-05	0.000404	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTGS2—melanoma	9.84e-05	0.0004	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CD—melanoma	9.21e-05	0.000375	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALB—melanoma	9.09e-05	0.00037	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CA—melanoma	8.78e-05	0.000357	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTEN—melanoma	8.58e-05	0.000349	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CA—melanoma	8.2e-05	0.000333	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CA—melanoma	8.2e-05	0.000333	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CB—melanoma	8.03e-05	0.000327	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTGS2—melanoma	7.95e-05	0.000324	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CA—melanoma	7.59e-05	0.000309	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AKT1—melanoma	7.17e-05	0.000292	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTEN—melanoma	6.94e-05	0.000282	CbGpPWpGaD
Metolazone—CA7—Metabolism—AKT1—melanoma	6.7e-05	0.000272	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AKT1—melanoma	6.7e-05	0.000272	CbGpPWpGaD
Metolazone—CA12—Metabolism—AKT1—melanoma	6.2e-05	0.000252	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CA—melanoma	6.05e-05	0.000246	CbGpPWpGaD
Metolazone—CA4—Metabolism—AKT1—melanoma	4.95e-05	0.000201	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CA—melanoma	4.89e-05	0.000199	CbGpPWpGaD
Metolazone—CA9—Metabolism—AKT1—melanoma	4e-05	0.000163	CbGpPWpGaD
